Novavax begins early-stage trial for combined flu/COVID-19 vaccine

Canada News News

Novavax begins early-stage trial for combined flu/COVID-19 vaccine
Canada Latest News,Canada Headlines
  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 55%

Trial results are expected in the first half of 2022.

Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants.Vaccine developer Novavax said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.

The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been previously infected with the coronavirus or given an authorizedParticipants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its influenza shot NanoFlu along with an adjuvant or vaccine booster.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TODAYshow /  🏆 389. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax begins early-stage trial for combined influenza/COVID-19 vaccineNovavax begins early-stage trial for combined influenza/COVID-19 vaccineVaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
Read more »

Novavax begins early-stage trial for combined influenza/COVID-19 vaccineNovavax begins early-stage trial for combined influenza/COVID-19 vaccineParticipants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster. 'Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen,' Gregory Glenn, President of Research and Development at Novavax, said in a statement. Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants.
Read more »

Orrin Heatlie, early leader of Newsom recall movement, has contracted COVID-19Orrin Heatlie, early leader of Newsom recall movement, has contracted COVID-19Heatlie, a retired Yolo County sheriff's deputy, said his case is mild and he is recovering at home.
Read more »

New Zealand marks downward trend in new COVID-19 casesNew Zealand marks downward trend in new COVID-19 casesNew Zealand reported a further fall in locally acquired COVID-19 cases on Wednesday, as the largely coronavirus-free nation looks to eradicate an outbreak of the highly infectious Delta variant.
Read more »

COVID-19 disruption causing many deaths from TB, AIDS in poorest countries, fund saysCOVID-19 disruption causing many deaths from TB, AIDS in poorest countries, fund saysHundreds of thousands of people will die of tuberculosis left untreated because of disruption to healthcare systems in poor countries caused by the COVID-19 pandemic, a global aid fund said.
Read more »

UN climate conference 'must go ahead' despite calls for postponement due to Covid-19, official saysUN climate conference 'must go ahead' despite calls for postponement due to Covid-19, official saysThe president of the UN climate change conference insisted Tuesday that the event scheduled for November in Glasgow 'must go ahead in person,' after a network of 1,500 civil society groups called for the negotiations to be postponed.
Read more »



Render Time: 2025-04-12 22:42:47